학술논문

LENVATINIB AND PEMBROLIZUMAB IN ADVANCED ENDOMETRIAL CARCINOMA (EC): LONG-TERM EFFICACY AND SAFETY UPDATE FROM A PHASE 1B/2 STUDY
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2021, 9 pA381-pA381, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426